ArticleNorthern clinics of Istanbul2025
Fetal echocardiography: A nine-year experience at a single tertiary center.
Article in Northern clinics of Istanbul, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Intracellular Ionic Remodeling During Fetal Development of Hereditary Cardiomyopathy of the Hamster.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveFetal echocardiography is a vital diagnostic tool used during pregnancy to evaluate the structure and function of the fetal heart. It allows for the early detection of congenital heart diseases (CHDs) and fetal arrhythmias, enabling timely prenatal counseling, perinatal planning, and therapeutic interventions when necessary. While routine obstetric ultrasounds may detect basic structural anomalies, fetal echocardiography provides more detailed anatomical and functional information, particularly in high-risk pregnancies. This study presents a nine-year experience of fetal echocardiography at a tertiary center, focusing on diagnostic accuracy, clinical contribution, and postnatal outcomes.
methodsWe retrospectively analyzed 405 fetuses who underwent fetal echocardiography between March 2016 and March 2025. All evaluations were performed by an experienced pediatric cardiologist using standard imaging protocols. Fetal cardiac findings and postnatal confirmation data were assessed.
resultsMajor structural cardiac anomalies were identified in 48 fetuses (11.9%), with the most common being Tetralogy of Fallot and Transposition of the Great Arteries. Minor findings such as echogenic intracardiac focus, premature atrial contractions, and small ventricular septal defects (VSDs) were seen in 104 cases (25.7%). Significant arrhythmias, including supraventricular tachycardia and complete heart block, were detected in 14 cases (3.5%).
conclusionFetal echocardiography is a reliable, non-invasive method for the early and accurate diagnosis of fetal cardiac anomalies. It facilitates appropriate prenatal referral and postnatal care planning, ultimately improving neonatal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.